Metastatic Breast Cancer Treatment Challenges

EP. 1: Introduction and Exploration of Fulvestrant in Breast Cancer

June 9th 2013

EP. 2: Combination of Anastrozole and Fulvestrant in MBC

June 9th 2013

EP. 3: BOLERO-2 Trial: Everolimus in Metastatic Breast Cancer

June 9th 2013

EP. 4: Management of mTOR Inhibitor Side Effects in Breast Cancer

June 9th 2013

EP. 5: EMILIA Trial: T-DM1 in Metastatic Breast Cancer

June 9th 2013

EP. 6: Frontline T-DM1 in HER2+ Metastatic Breast Cancer

June 9th 2013

EP. 7: CLEOPATRA Trial: Frontline Pertuzumab for HER2+ MBC

June 9th 2013

EP. 8: MA.31 Trial: Taxane With Lapatinib or Trastuzumab

June 9th 2013

EP. 9: Treatment With Eribulin in Metastatic Breast Cancer

June 9th 2013

EP. 10: Case Study: Treating HER2-Positive MBC, Part I

June 9th 2013

EP. 11: Case Study: Treating HER2-Positive MBC, Part II

June 9th 2013

EP. 12: Paclitaxel With Pertuzumab Plus Trastuzumab in MBC

June 9th 2013

EP. 13: Case Study: Treating HR+ and HER2- Breast Cancer

June 9th 2013

EP. 14: Managing Bone Health in Metastatic Breast Cancer

June 9th 2013

EP. 15: Surgical Removal of Primary Tumors in Stage IV MBC

June 9th 2013

EP. 16: Case Study: Metastatic Triple-Negative Breast Cancer

June 9th 2013

EP. 17: Personalized Medicine in Triple-Negative Breast Cancer

June 9th 2013

EP. 18: Conclusion and Final Thoughts on Managing Breast Cancer

June 9th 2013

x